ビオフェルミン製薬(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証1部医薬品4517/E00960BIOFERMIN PHARMACEUTICAL CO.,LTD.
公表日公表担保貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比
2016/12/09日証協無担保106株-48.54%0株0.00%9,514株+1.06%
2016/12/09日証協有担保19,894株+1.02%0株-100.00%19,406株+2.64%
2016/12/02日証協無担保206株+94.34%0株0.00%9,414株-3.09%
2016/12/02日証協有担保19,694株-10.46%500株-16.67%18,906株+3.28%
2016/11/25日証協無担保106株0.00%0株0.00%9,714株0.00%
2016/11/25日証協有担保21,994株-0.45%600株0.00%18,306株-2.14%
2016/11/18日証協無担保106株0.00%0株0.00%9,714株+12.86%
2016/11/18日証協有担保22,094株-14.68%600株-25.00%18,706株-0.50%
2016/11/11日証協無担保0株0.00%0株0.00%8,607株-2.26%
2016/11/11日証協有担保25,894株-1.52%800株-38.46%18,800株-2.08%
2016/11/04日証協無担保0株0.00%0株0.00%8,806株-5.37%
2016/11/04日証協有担保26,294株+1.44%1,300株0.00%19,200株+4.35%
2016/10/28日証協無担保0株-100.00%0株0.00%9,306株-1.12%
2016/10/28日証協有担保25,921株+1.97%1,300株+160.00%18,400株+2.79%
2016/10/21日証協無担保100株0.00%0株0.00%9,411株+4.44%
2016/10/21日証協有担保25,421株-14.18%500株+25.00%17,900株-0.56%
2016/10/14日証協無担保100株-50.00%0株0.00%9,011株+5.87%
2016/10/14日証協有担保29,621株+1.02%400株0.00%18,000株-2.70%
2016/10/07日証協無担保200株+100.00%0株0.00%8,511株+30.84%
2016/10/07日証協有担保29,321株-0.10%400株-15.43%18,500株+1.65%
2016/09/30日証協無担保100株-50.00%0株0.00%6,505株-30.14%
2016/09/30日証協有担保29,350株-12.52%473株-86.38%18,200株-15.74%
2016/09/23日証協無担保200株0.00%0株0.00%9,311株+1.09%
2016/09/23日証協有担保33,550株+44.76%3,473株-3.53%21,600株+1.89%
2016/09/16日証協無担保200株0.00%0株0.00%9,211株-2.13%
2016/09/16日証協有担保23,177株-6.08%3,600株-16.28%21,200株-10.17%
2016/09/09日証協無担保0株-100.00%0株0.00%9,411株-1.05%
2016/09/09日証協有担保24,677株-0.71%4,300株-6.52%23,600株-1.82%
2016/09/02日証協無担保700株0.00%0株0.00%9,511株+3.31%
2016/09/02日証協有担保24,854株-2.26%4,600株+6.98%24,038株0.00%
2016/08/26日証協無担保700株+40.00%0株0.00%9,206株+2.21%
2016/08/26日証協有担保25,428株+0.79%4,300株+13.16%24,038株+0.42%
2016/08/19日証協無担保500株+66.67%0株0.00%9,007株+4.65%
2016/08/19日証協有担保25,228株-0.50%3,800株0.00%23,938株+1.15%
2016/08/12日証協無担保300株0.00%0株0.00%8,607株+1.19%
2016/08/12日証協有担保25,356株-1.32%3,800株+2.70%23,666株-1.12%
2016/08/05日証協無担保0株-100.00%0株0.00%8,506株-1.16%
2016/08/05日証協有担保25,694株+3.65%3,700株-7.50%23,934株+2.28%

※株式分割は考慮していませんのでご注意ください。

Page Top